LGD-4033 (Ligandrol)

LGD-4033, commonly known as Ligandrol, is a selective androgen receptor modulator (SARM) developed for research involving androgen receptor signaling and anabolic pathways. It is designed to bind selectively to androgen receptors in muscle and bone tissue, making it a compound of interest in studies focused on lean mass, strength signaling, and musculoskeletal research.

Key Characteristics

• Selective androgen receptor modulator (SARM)

• High binding affinity to androgen receptors

• Studied for lean mass and muscle signaling pathways

• Non-steroidal structure

• Commonly supplied in capsule, liquid, or raw powder form (research use)

Research Applications

LGD-4033 has been investigated in controlled research settings for:

• Lean body mass development models

• Muscle protein synthesis pathways

• Bone density research

• Androgen receptor selectivity studies

• Catabolic state and muscle preservation research

Its selective mechanism distinguishes it from traditional anabolic steroids, making it a compound of interest in receptor-targeted research.

60 caps x 12 mg